Internal Medicine

An open-label extension of GLAGOV shows the monoclonal antibody plus statin therapy is not associated with any new safety concerns.

Patients treated at verified level I trauma centers are more likely to receive 5-6 evidence-based practices.

APR-OD031 will be taken in combination with a patented drug delivery system to treat the rare inherited disease.

A study’s proposed findings of increased coronavirus risk shows how presenting half of a fact can influence our care during a pandemic.

A pediatric version of the ASTHMAXcel mobile application will include games.

What effect may professional athletes receiving asymptomatic tests have on the public perception of the coronavirus?

Rishi Singh, MD, of Cole Eye Institute, discusses steps to take to help prevent the spread of coronavirus in ophthalmology practices.

Patients with alkaptonuria have a higher prevalence of primary hypothyroidism.

Additional research can help better understand the risks and benefits of cannabinoids for the treatment of acute pain.

Robert Brown, MD, advises liver transplant recipients to exhibit extreme caution in the face of the coronavirus outbreak.

An ACC board member explains the major cardiology college's decision to move the meeting online during the COVID-19 pandemic.

Digital tools can be leveraged to help treat more patients remotely.

The Mount Sinai expert and ACC late-breaking presentation panelist highlights her most anticipated trial data and discussions in the upcoming meeting.

Executive Director of Interventional Cardiovascular Programs at Brigham and Women's discusses some research he took part in being presented at this year's conference.

Surgical intervention leads to a bigger reduction in pain intensity compared to a more conservative approach.

In a new study, investigators discover 7-8 hours as the optimal sleep duration for reducing the risk of strokes and heart disease.

Muthiah Vaduganathan, MD, MPH, discusses how research of the add-on drug class will continue to evolve into 2021.

What's known about at-risk cardiometabolic patient care during the pandemic.

The three-year study represents the largest long-term kinetic immunotherapy trial.

While the opioid epidemic has had a devastating impact on American families, there is some hope that the future is bright.

A Keck Medicine expert explains how the California-based institution has pooled resources and personnel during their pandemic response.

Results of a study show the efficacy of an artificial intelligence chatbot for patients with asthma and pregnant women.

Lisa Stein Gold, MD, of Henry Ford Hospital discusses promising phase 2 data for a new PDE4 inhibitor.

The document, which includes 11 clinical competencies for NPs and PAs, is the first of its kind from the American College of Cardiology.

In the phase 2 PIONEER trial, patients taking avapritinib self-reported improvements in quality of life.